P53 deletion is not a frequent event in multiple myeloma

British Journal of Haematology

Volumn 106, Issue 3, 1999, Pages 717-719

  Avet Loiseau, Hervé ^a,c   Li, Jian Yong ^a   Godon, Catherine ^a   Morineau, Nadine ^a   Daviet, Axelle ^a   Harousseau, Jean Luc ^a   Facon, Thierry ^b   Bataille, Régis ^a  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c INSTITUT DE BIOLOGIE   (France)

Author keywords

Cytogenetics; Fluorescence in situ hybridization; Multiple myeloma; P53

Indexed keywords

ARTICLE; CANCER GENETICS; CLINICAL ARTICLE; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE LOCUS; HUMAN; MULTIPLE MYELOMA; PRIORITY JOURNAL;

GENE DELETION; GENES, P53; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MULTIPLE MYELOMA;

EID: 0032854511     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01615.x     Document Type: Article

References (10)

1. Avet-Loiseau, H., Li, J.Y., Facon, T., Brigaudeau, C., Morineau, N., Maloisel, F., Rapp, M.J., Talmant, P., Trimoreau, F., Jaccard, A., Harousseau, J.L. & Bataille, R. (1998) High incidence of translations t(11;14)(q13;q52) and t(4;14)(p16;q32) in patients with plasma cell malignancies. Cancer Research, 58, 5640-5645.
2. Dohner, H., Fischer, K., Beutz, M., Hansen, K., Benner, A., Cabot, G., Diehl, D., Schlenk, R., Coy, J., Stilgenbauer, S., Volkmann, M., Galle, P.R., Poustka, A., Hunstein, W. & Lichter, P. (1995) p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias. Blood, 85, 1580-1589.
3. Drach, J., Ackermann, J., Fritz, E., Kromer, E., Schuster, R., Gisslinger, H., DeSantis, M., Zojer, N., Fiegl, M., Roka, S., Schuster, J., Heinz, R., Ludwig, H. & Huber, H. (1998) Presence of p53 gene deletion in patients with multiple myeloma predicts for short survival after conventional-dose chemotherapy. Blood, 92, 802-809.
4. Garcia-Marco, J.A., Caldas, C., Price, C.M., Wiedemann, L.M., Ashworth, A. & Catovsky, D. (1996) Frequent somatic deletion of the 13q12.3 locus encompassing BRCA2 in chronic lymphocytic leukemia. Blood, 88, 1568-1575.
5. Levine, A.J. (1997) p53, the cellular gatekeeper for growth and division. Cell, 88, 323-331.
6. Neri, A., Baldini, L., Trecca, D., Cro, L., Polli, E. & Maiolo, A.T. (1993) p53 gene mutations in multiple myeloma are associated with advanced forms of malignancy. Blood, 81, 128-135.
7. Nishida, K., Tamura, A., Nakazawa, N., Ueda, Y., Abe, T., Matsuda, F., Kashima, K. & Taniwaki, M. (1997) The Ig heavy chain gene is frequently involved in chromosomal translations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization. Blood, 90, 526-534.
8. Panayiotidis, P., Ganchaguru, K., Rowntree, C., Jabbar, S.A.B., Hoffbrand, V.A. & Foroni, L., (1997) Lack of clonal BRCA2 gene deletion on chromosome 13 in chronic lymphocytic leukaemia. British Journal of Haematology, 97, 844-847.
9. Portier, M., Moles, J.P., Mazars, G.R., Jeanteur, P., Bataille, R., Klein, B. & Theillet, C. (1992) p53 and RAS gene mutations in multiple myeloma. Oncogene, 7, 2539.
10. Preudhomme, C., Facon, T., Zandecki, M., Vanrumbeke, M., Lai, J.L., Nataf, E., Loucheux-Lefebvre, M.H., Kerckaert, J.P. & Fenaux, P. (1992) Rare occurrence of P53 gene mutations in multiple myeloma. British Journal of Haematology, 81, 440-443.